Permira completes buyout of Cambrex

Permira has closed its acquisition of Cambrex Corporation, a small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle.

4 December 2019•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail

Related articles